Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: A. Lasagna, F. Bergami, D. Lilleri, E. Percivalle, M. Quaccini, N. Alessio, G. Comolli, A. Sarasini, J. C. Sammartino, A. Ferrari, F. Arena, S. Secondino, D. Cicognini, R. Schiavo, G. Lo Cascio, L. Cavanna, F. Baldanti, P. Pedrazzoli, I. Cassaniti

Journal title: ESMO Open

Journal number: 7

Journal publisher: Elsevier BV

Published year: 2022

DOI identifier: 10.1016/j.esmoop.2022.100458

ISSN: 0020-0255